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A B S T R A C T
In order to investigate the contribution of the atrial natriuretic factor (ANF) gene in
pathogenesis of essential arterial hypertension (EAH), we analyzed the ScaI gene poly-
morphism of the ANF gene in a group of children with EAH. Fifty-eight children, aged
8–19 years, with the diagnosis of EAH were included in the association study and were
compared to 57 subjects with normal blood pressure (the control group). Arterial hyper-
tension was defined as systolic/diastolic blood pressure higher than the 95th age-gender-
-height percentile of the adopted reference values. We failed to demonstrate an associa-
tion between the ScaI ANF gene polymorphism and EAH in childhood (OR=2; 95% CI
0.9–4.2; p=0.07), however, we provided evidence of an interaction between the ScaI ANF
gene polymorphism and obesity defined as BMI over the 85th percentile (OR=13.1; 95%
CI 1.6–106; p<0.001).
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Introduction
Several candidate genes for multifac-
torial cardiovascular disorders have been
tested in the general population as well
as in diabetic patients in Slavic popula-
tions1–11. Essential arterial hypertension
(EAH) is a complex disease influenced by
various genetic and environmental fac-
tors12. Between 1% and 3 % of children
are diagnosed with EAH12. Due to early
expression of EAH in children, it could be
speculated that genetic factors play a more
important role than environmental factors
in the development of hypertension12–16.
Several complex physiological systems af-
fect blood pressure, including atrial nat-
riuretic factor (ANF)12,18,19.
The ANF has several effects, which
might influence blood pressure, such as
suppression of the renin activity, inhibition
of the synthesis and release of aldostero-
ne, vasodilatation, diuresis and natriure-
sis18,20. The ANF is another important
candidate gene for arterial hypertension
in childhood; genetic variants of the ANF
could influence blood pressure. So far,
there has not been an association study
about the ScaI gene polymorphism of
ANF in Caucasians with EAH; however,
there have been one report for African
Americans and one for the Japanese with
EAH published13,21.
In this case-control association study
we analyzed the contribution of genetic
variability of the ANF to the predisposi-
tion for EAH in childhood. For this purpose
we analyzed the ScaI gene polymorphism
of ANF in a group of Caucasian children
with EAH.
Materials and Methods
Fifty-eight patients with essential arte-
rial hypertension, aged 8–19 years, and
57 subjects in the control group were en-
rolled in the study. Arterial hypertension
was defined as systolic/diastolic BP (blo-
od pressure) measurements higher than
the 95th age-gender-height percentile of
the adopted reference BP values22. To ex-
clude the cases of white-coat hyperten-
sion, ambulatory blood pressure monitor
was used23. In our study, the values consi-
dered »normal« for both systolic and dias-
tolic pressure were based on data obtai-
ned from the multicentric European study
performed on healthy children and ado-
lescents23. The device was adjusted for
measurements every 20 minutes during
the daytime (from 7 a.m. to 9 p.m.) and 30
minutes during the nighttime. Children
with secondary hypertension were exclu-
ded from the study. The patients and con-
trol subjects came from independent fami-
lies from the same region, and they were
all Slovenians. The data and blood sam-
ples of age-matched controls were obtained
from pediatricians. The national medical
ethics committee approved the study pro-
tocol. After informed consent was obtai-
ned from the patients’ parents and con-
trol subjects, a detailed interview was
made. Obesity was defined when body
mass index (BMI) was greater than the
85th percentile per age per sex24.
The PCR reaction for ScaI ANF gene
polymorphism was carried out in a 15-l
reaction volume containing 0.17 mM
dNTP (Gibco, UK), 10 mM TRIS HCl buf-
fer, 1 mM MgCl2, 0.2 M of each primer
(5-GGC ACA CTC ATA CAT GAA
GCT GAC T-3, 5-GCA GTC TGT
CCC TAG GCC CA-3 for ScaI NAF ge-
ne polymorphism), 500 ng of genomic
DNA and 0.75 units of Taq DNA polymer-
ase (Gibco, UK). DNA was amplified for
30 cycles with denaturation at 94 °C for 1
min, annealing at 61 °C for 1 minute, and
primer extension at 72 °C for 40 seconds.
8 l of the PCR product was digested
overnight at 37 °C with 10 units of ScaI,
and the fragments were then separated
on 8 % polyacrylamide gels25. The geno-
type polymorphism was detected as either
A2A2 (presence of restriction site on both
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alleles), or A1A2 (absence of a restriction
site on one allele), or A1A1 (absence of
restriction site on both alleles).
Differences in mean values were ana-
lyzed by Student’s t-test and presented as
means ± standard deviation (SD). Chi-
square (2) test was used to compare dis-
crete variables. Genotypic odds ratios
(OR) for EAH with 95% confidence inter-
vals (CI) were calculated with two-tailed
p values. Statistical analyses were per-
formed using the SPSS program for Win-
dows 98, version 11 (SPSS Inc., Illinois).
Results
Characteristics of the patients and
control subjects are listed in Table 1. The
ANF genotype distribution in cases and
controls (Table 2) were compatible with
Hardy-Weinberg expectations (ANF: ca-
ses p=0.2, 2=1.66; ANF: controls p=
0.524, 2=3.763).
Univariate analysis (Table 3) showed
a trend towards the association between
the A1A1 genotype of the ScaI ANF gene
polymorphism and EAH in childhood
(OR=2; 95 % CI 0.9–4.2; p=0.07). Additio-
nally, an interactive effect on the risk of
EAH was found between obesity and the
A1A1 genotype of the ScaI NAF polymor-
phism (OR=13.1; 95 % CI 1.6–106; p<
0.001) (Table 3).
Discussion
In the study we failed to demonstrate
an association between the ScaI ANF ge-
ne polymorphism and EAH in childhood.
Lack of association between the ScaI
ANF gene polymorphism and EAH is in
accordance with two other studies in
adults of different origin, Japanese and
African American13,21. Interestingly, how-
ever, there are great differences among
populations: A2 allele was very rare in
the Japanese population (in 1.6 % of ca-
ses and in 4.6 % of controls), higher in our
study in Caucasians (in 25.8 % of cases
and in 36 % of controls), and even higher
in African Americans (in 58.3 % of cases
and in 61.4 % of controls)13,21. Moreover,
case-control association studies are prone
to type II errors (i.e., failing to reject the
null hypothesis – that there is no differ-
ence in allelic distributions between the
two groups – when it is false). One way to
circumvent this problem is to increase
the study sample.
In this study, however, we found a
trend (p=0.07) towards an association be-
tween the A1A1 genotype of the ScaI
gene polymorphism and childhood EAH.
Although statistical significance did not
reach p<0.05, the result obtain could indi-
cate the involvement of the polymor-
phism as a risk factor in EAH. However,
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TABLE 1
CHARACTERISTICS OF PATIENTS WITH EAH AND CONTROLS
Characteristics Patients Controls p value
Number 58 57 ns
Age (years) 14.7 ± 2.3 13.9 ± 2.5 ns
Height (cm) 169.3 ± 14.4 154.5 ± 39.2 <0.001
Weight (kg) 74.3 ± 19.3 50.5 ± 18.2 <0.001
BMI (kg/m2) 25.8 ± 5.5 19.7 ± 2.9 <0.001
Systolic blood pressure (mmHg) 148.2 ± 22.8 110 ± 23.3 <0.001
Diastolic blood pressure (mmHg) 86.7 ± 17.6 67.5 ± 14.7 <0.001
Values are means ± SD
the result should be interpreted cau-
tiously because of a small sample.
Additionally, we provide evidence of
an interaction between the ScaI ANF
gene polymorphism and obesity defined
as BMI over the 85th percentile. Children
having the A1A1 genotype of the ScaI
ANF polymorphism might be at a higher
risk of increased blood pressure if they
are obese. Based on our results and on so-
me other studies it is reasonable to belie-
ve that the interaction between multiple
genes rather than variants of a single ge-
ne underlie the genetic basis of EAH15,16.
Sharma et al. (2000), who have systemat-
ically studied the entire human genome
for major susceptibility genes for EAH,
failed to demonstrate that a single region
makes a large contribution to its origin.
They provide evidence that EAH is likely
to be accounted for by several loci15. Futu-
re studies should therefore be oriented to-
wards revealing a complex network of a
variety of interacting genes, pathophysio-
logical conditions (obesity, gender), and
environmental factors.
In conclusion, we failed to demonstra-
te an association between the ScaI ANF
gene polymorphism and EAH in child-
hood; however, we demonstrate evidence
of interaction between the ScaI ANF gene
polymorphism and obesity defined as
BMI over the 85th percentile.
Acknowledgements
The authors thank Ms Mojca Pirc, BA,
for revising the English text.
620
R. Zorc-Pleskovi~ et al.: ANF and Arterial Hypertension, Coll. Antropol. 28 (2004) 2: 617–621
TABLE 2
DISTRIBUTION OF SCAI-ANF GENOTYPES AND ALLELES AMONG EAH PATIENTS AND CONTROLS
Variable Patients N (%) Controls N (%)
A1A1 genotype1 30 (51.7 %) 20 (35.1 %)
A1A2 genotype2 26 (44.8 %) 33 (57.9 %)
A2A2 genotype3 2 (3.4 %) 4 (7.0 %)
Allele distribution4
A1 allele 86 (74.1 %) 73 (74.0 %)
A2 allele 30 (25.9 %) 41 (36.0 %)
1 A1A1 genotype – absence of restriction site on both alleles
2 A1A2 genotype – absence of a restriction site on one allele
3 A2A2 genotype – presence of restriction site on both alleles
4 chi square=2.3, p=0.12
TABLE 3
INTERACTION BETWEEN THE SCAI GENE POLYMORPHISM OF THE ANF AND OBESITY
IN CHILDREN WITH EAH AND CONTROLS
Variable Patients N (%) Controls N (%) p OR (95 % CI)1
A1A1 genotype2 30 (52) 20 (35) 0.07 2 (0.9–4.2)
BMI>85 ‰ 3 35 (60) 8 (14) <0.001 9.5 (3.8–23.9)
A1A1 genotype + BMI>85 ‰ 11 (19) 1 (2) <0.001 13.1 (1.6–106)
1 Odds ratio (95 % confidence interval)
2 ScaI gene polymorphism of the ANF
3 BMI was greater than 85th percentile per age per sex
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POLIMORFIZAM ScaI GENA ZA ATRIJSKI NATRIURETSKI FAKTOR I
ESENCIJALNA ARTERIJSKA HIPERTENZIJA U DJETINJSTVU
S A @ E T A K
U namjeri utvr|ivanja uloge gena atrijalni natriuretski faktor (ANF) u patogenezi
esencijalne arterijske hipertenzije (EAH), ispitali smo ScaI polimorfizam ANF gena u
djece s EAH. Ispitivanu skupinu ~ini 58 djece u dobi 8–19 godina, s dijagnozom EAH, a
kontrolna skupina se sastoji od 57 ispitanika normalnog krvnog tlaka. Arterijska hi-
pertenzija dijagnosticirana je kao sistoli~ko/dijastoli~ko mjerenje krvnog tlaka iznad
95. percentile referentnih vrijednosti, uzimaju}i u obzir i dob, spol, visinu. Nije dokaza-
na povezanost ScaI ANF genskog polimorfizma i EAH u djece (OR=2; 95% CI 0.9–4.2;
p=0.07), me|utim, dokazali smo povezanost ScaI ANF genskog polimorfizma i pretilos-
ti dijagnosticirane kao BMI iznad 85. percentile (OR=13.1; 95% CI 1.6–106; p<0.001).
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